Gene Expression and Protein Abundance of Hepatic Drug Metabolizing Enzymes in Liver Pathology
Hepatic drug metabolizing enzymes (DMEs) markedly affect drug pharmacokinetics. Because liver diseases may alter enzymatic function and in turn drug handling and clinical efficacy, we investigated DMEs expression in dependence on liver pathology and liver failure state. In 5 liver pathologies (hepat...
Saved in:
Main Authors: | Marek Drozdzik (Author), Joanna Lapczuk-Romanska (Author), Christoph Wenzel (Author), Sylwia Szelag-Pieniek (Author), Mariola Post (Author), Łukasz Skalski (Author), Mateusz Kurzawski (Author), Stefan Oswald (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug-Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes
by: Florian Klomp, et al.
Published: (2020) -
Organic Cation Transporter 1 an Intestinal Uptake Transporter: Fact or Fiction?
by: Christoph Wenzel, et al.
Published: (2021) -
The Ontogeny of Cytochrome P450 Enzyme Activity and Protein Abundance in Conventional Pigs in Support of Preclinical Pediatric Drug Research
by: Joske Millecam, et al.
Published: (2018) -
Effects of a Common Eight Base Pairs Duplication at the Exon 7-Intron 7 Junction on Splicing, Expression, and Function of OCT1
by: Sarah Römer, et al.
Published: (2021) -
Vitamin-D: Deficiency in abundance
by: Omprakash Gupta
Published: (2014)